WHO move helps Merck's Gardasil into poor markets
This article was originally published in Scrip
Executive Summary
The World Health Organization has prequalified Merck & Co's cervical cancer vaccine, Gardasil, meaning it is now eligible for procurement by UN agencies, such as the children's fund (UNICEF) and the Pan American Health Organization, for use in national immunisation programmes.